 | • レポートコード：MRC2Q12-19362 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、72ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、処方カンナビジオール（CBD）オイルのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 処方カンナビジオール（CBD）オイルのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 処方カンナビジオール（CBD）オイルの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 処方カンナビジオール（CBD）オイルのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの処方カンナビジオール（CBD）オイルの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の処方カンナビジオール（CBD）オイルの売上および2028年までの予測に焦点を当てています。 処方カンナビジオール（CBD）オイルのグローバル主要企業には、Jazz Pharmaceuticals plc、Tilray Irelandなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 処方カンナビジオール（CBD）オイル市場は、タイプとアプリケーションによって区分されます。世界の処方カンナビジオール（CBD）オイル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 有機大麻油、非有機大麻油 【アプリケーション別セグメント】 オンライン販売、オフライン販売 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 処方カンナビジオール（CBD）オイル製品概要 - タイプ別市場（有機大麻油、非有機大麻油） - アプリケーション別市場（オンライン販売、オフライン販売） - 調査の目的 ・エグゼクティブサマリー - 世界の処方カンナビジオール（CBD）オイル販売量予測2017-2028 - 世界の処方カンナビジオール（CBD）オイル売上予測2017-2028 - 処方カンナビジオール（CBD）オイルの地域別販売量 - 処方カンナビジオール（CBD）オイルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別処方カンナビジオール（CBD）オイル販売量 - 主要メーカー別処方カンナビジオール（CBD）オイル売上 - 主要メーカー別処方カンナビジオール（CBD）オイル価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（有機大麻油、非有機大麻油） - 処方カンナビジオール（CBD）オイルのタイプ別販売量 - 処方カンナビジオール（CBD）オイルのタイプ別売上 - 処方カンナビジオール（CBD）オイルのタイプ別価格 ・アプリケーション別市場規模（オンライン販売、オフライン販売） - 処方カンナビジオール（CBD）オイルのアプリケーション別販売量 - 処方カンナビジオール（CBD）オイルのアプリケーション別売上 - 処方カンナビジオール（CBD）オイルのアプリケーション別価格 ・北米市場 - 北米の処方カンナビジオール（CBD）オイル市場規模（タイプ別、アプリケーション別） - 主要国別の処方カンナビジオール（CBD）オイル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの処方カンナビジオール（CBD）オイル市場規模（タイプ別、アプリケーション別） - 主要国別の処方カンナビジオール（CBD）オイル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の処方カンナビジオール（CBD）オイル市場規模（タイプ別、アプリケーション別） - 主要国別の処方カンナビジオール（CBD）オイル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の処方カンナビジオール（CBD）オイル市場規模（タイプ別、アプリケーション別） - 主要国別の処方カンナビジオール（CBD）オイル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの処方カンナビジオール（CBD）オイル市場規模（タイプ別、アプリケーション別） - 主要国別の処方カンナビジオール（CBD）オイル市場規模（トルコ、サウジアラビア） ・企業情報 Jazz Pharmaceuticals plc、Tilray Ireland ・産業チェーン及び販売チャネル分析 - 処方カンナビジオール（CBD）オイルの産業チェーン分析 - 処方カンナビジオール（CBD）オイルの原材料 - 処方カンナビジオール（CBD）オイルの生産プロセス - 処方カンナビジオール（CBD）オイルの販売及びマーケティング - 処方カンナビジオール（CBD）オイルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 処方カンナビジオール（CBD）オイルの産業動向 - 処方カンナビジオール（CBD）オイルのマーケットドライバー - 処方カンナビジオール（CBD）オイルの課題 - 処方カンナビジオール（CBD）オイルの阻害要因 ・主な調査結果 |
A prescription cannabidiol (CBD) oil is considered an effective anti-seizure medication.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Prescription Cannabidiol (CBD) Oil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Prescription Cannabidiol (CBD) Oil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Prescription Cannabidiol (CBD) Oil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Prescription Cannabidiol (CBD) Oil include Jazz Pharmaceuticals plc and Tilray Ireland etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Prescription Cannabidiol (CBD) Oil manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Prescription Cannabidiol (CBD) Oil market. Further, it explains the major drivers and regional dynamics of the global Prescription Cannabidiol (CBD) Oil market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Jazz Pharmaceuticals plc
Tilray Ireland
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by sales channel segments based on sales, price, and value for the period 2017-2028.
Prescription Cannabidiol (CBD) Oil Segment by Type
Organic Cannabis Oil
Non-Organic Cannabis Oil
Prescription Cannabidiol (CBD) Oil Segment by Sales Channel
Online Sales
Offline Sales
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Prescription Cannabidiol (CBD) Oil market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Prescription Cannabidiol (CBD) Oil, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Prescription Cannabidiol (CBD) Oil, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Prescription Cannabidiol (CBD) Oil, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prescription Cannabidiol (CBD) Oil sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Prescription Cannabidiol (CBD) Oil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Prescription Cannabidiol (CBD) Oil sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Jazz Pharmaceuticals plc and Tilray Ireland etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Prescription Cannabidiol (CBD) Oil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Prescription Cannabidiol (CBD) Oil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by sales channel and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by sales channel and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by sales channel and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by sales channel and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by sales channel and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Cannabidiol (CBD) Oil sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Prescription Cannabidiol (CBD) Oil Product Introduction
1.2 Market by Type
1.2.1 Global Prescription Cannabidiol (CBD) Oil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Organic Cannabis Oil
1.2.3 Non-Organic Cannabis Oil
1.3 Market by Sales Channel
1.3.1 Global Prescription Cannabidiol (CBD) Oil Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prescription Cannabidiol (CBD) Oil Sales Estimates and Forecasts 2017-2028
2.2 Global Prescription Cannabidiol (CBD) Oil Revenue Estimates and Forecasts 2017-2028
2.3 Global Prescription Cannabidiol (CBD) Oil Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prescription Cannabidiol (CBD) Oil Sales by Region
2.4.1 Global Prescription Cannabidiol (CBD) Oil Sales by Region (2017-2022)
2.4.2 Global Sales Prescription Cannabidiol (CBD) Oil by Region (2023-2028)
2.5 Global Prescription Cannabidiol (CBD) Oil Revenue by Region
2.5.1 Global Prescription Cannabidiol (CBD) Oil Revenue by Region (2017-2022)
2.5.2 Global Prescription Cannabidiol (CBD) Oil Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prescription Cannabidiol (CBD) Oil Sales by Manufacturers
3.1.1 Global Top Prescription Cannabidiol (CBD) Oil Manufacturers by Sales (2017-2022)
3.1.2 Global Prescription Cannabidiol (CBD) Oil Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prescription Cannabidiol (CBD) Oil in 2021
3.2 Global Prescription Cannabidiol (CBD) Oil Revenue by Manufacturers
3.2.1 Global Prescription Cannabidiol (CBD) Oil Revenue by Manufacturers (2017-2022)
3.2.2 Global Prescription Cannabidiol (CBD) Oil Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prescription Cannabidiol (CBD) Oil Revenue in 2021
3.3 Global Prescription Cannabidiol (CBD) Oil Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prescription Cannabidiol (CBD) Oil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prescription Cannabidiol (CBD) Oil Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prescription Cannabidiol (CBD) Oil Sales by Type
4.1.1 Global Prescription Cannabidiol (CBD) Oil Historical Sales by Type (2017-2022)
4.1.2 Global Prescription Cannabidiol (CBD) Oil Forecasted Sales by Type (2023-2028)
4.1.3 Global Prescription Cannabidiol (CBD) Oil Sales Market Share by Type (2017-2028)
4.2 Global Prescription Cannabidiol (CBD) Oil Revenue by Type
4.2.1 Global Prescription Cannabidiol (CBD) Oil Historical Revenue by Type (2017-2022)
4.2.2 Global Prescription Cannabidiol (CBD) Oil Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prescription Cannabidiol (CBD) Oil Revenue Market Share by Type (2017-2028)
4.3 Global Prescription Cannabidiol (CBD) Oil Price by Type
4.3.1 Global Prescription Cannabidiol (CBD) Oil Price by Type (2017-2022)
4.3.2 Global Prescription Cannabidiol (CBD) Oil Price Forecast by Type (2023-2028)
5 Market Size by Sales Channel
5.1 Global Prescription Cannabidiol (CBD) Oil Sales by Sales Channel
5.1.1 Global Prescription Cannabidiol (CBD) Oil Historical Sales by Sales Channel (2017-2022)
5.1.2 Global Prescription Cannabidiol (CBD) Oil Forecasted Sales by Sales Channel (2023-2028)
5.1.3 Global Prescription Cannabidiol (CBD) Oil Sales Market Share by Sales Channel (2017-2028)
5.2 Global Prescription Cannabidiol (CBD) Oil Revenue by Sales Channel
5.2.1 Global Prescription Cannabidiol (CBD) Oil Historical Revenue by Sales Channel (2017-2022)
5.2.2 Global Prescription Cannabidiol (CBD) Oil Forecasted Revenue by Sales Channel (2023-2028)
5.2.3 Global Prescription Cannabidiol (CBD) Oil Revenue Market Share by Sales Channel (2017-2028)
5.3 Global Prescription Cannabidiol (CBD) Oil Price by Sales Channel
5.3.1 Global Prescription Cannabidiol (CBD) Oil Price by Sales Channel (2017-2022)
5.3.2 Global Prescription Cannabidiol (CBD) Oil Price Forecast by Sales Channel (2023-2028)
6 North America
6.1 North America Prescription Cannabidiol (CBD) Oil Market Size by Type
6.1.1 North America Prescription Cannabidiol (CBD) Oil Sales by Type (2017-2028)
6.1.2 North America Prescription Cannabidiol (CBD) Oil Revenue by Type (2017-2028)
6.2 North America Prescription Cannabidiol (CBD) Oil Market Size by Sales Channel
6.2.1 North America Prescription Cannabidiol (CBD) Oil Sales by Sales Channel (2017-2028)
6.2.2 North America Prescription Cannabidiol (CBD) Oil Revenue by Sales Channel (2017-2028)
6.3 North America Prescription Cannabidiol (CBD) Oil Market Size by Country
6.3.1 North America Prescription Cannabidiol (CBD) Oil Sales by Country (2017-2028)
6.3.2 North America Prescription Cannabidiol (CBD) Oil Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Prescription Cannabidiol (CBD) Oil Market Size by Type
7.1.1 Europe Prescription Cannabidiol (CBD) Oil Sales by Type (2017-2028)
7.1.2 Europe Prescription Cannabidiol (CBD) Oil Revenue by Type (2017-2028)
7.2 Europe Prescription Cannabidiol (CBD) Oil Market Size by Sales Channel
7.2.1 Europe Prescription Cannabidiol (CBD) Oil Sales by Sales Channel (2017-2028)
7.2.2 Europe Prescription Cannabidiol (CBD) Oil Revenue by Sales Channel (2017-2028)
7.3 Europe Prescription Cannabidiol (CBD) Oil Market Size by Country
7.3.1 Europe Prescription Cannabidiol (CBD) Oil Sales by Country (2017-2028)
7.3.2 Europe Prescription Cannabidiol (CBD) Oil Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prescription Cannabidiol (CBD) Oil Market Size by Type
8.1.1 Asia Pacific Prescription Cannabidiol (CBD) Oil Sales by Type (2017-2028)
8.1.2 Asia Pacific Prescription Cannabidiol (CBD) Oil Revenue by Type (2017-2028)
8.2 Asia Pacific Prescription Cannabidiol (CBD) Oil Market Size by Sales Channel
8.2.1 Asia Pacific Prescription Cannabidiol (CBD) Oil Sales by Sales Channel (2017-2028)
8.2.2 Asia Pacific Prescription Cannabidiol (CBD) Oil Revenue by Sales Channel (2017-2028)
8.3 Asia Pacific Prescription Cannabidiol (CBD) Oil Market Size by Region
8.3.1 Asia Pacific Prescription Cannabidiol (CBD) Oil Sales by Region (2017-2028)
8.3.2 Asia Pacific Prescription Cannabidiol (CBD) Oil Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prescription Cannabidiol (CBD) Oil Market Size by Type
9.1.1 Latin America Prescription Cannabidiol (CBD) Oil Sales by Type (2017-2028)
9.1.2 Latin America Prescription Cannabidiol (CBD) Oil Revenue by Type (2017-2028)
9.2 Latin America Prescription Cannabidiol (CBD) Oil Market Size by Sales Channel
9.2.1 Latin America Prescription Cannabidiol (CBD) Oil Sales by Sales Channel (2017-2028)
9.2.2 Latin America Prescription Cannabidiol (CBD) Oil Revenue by Sales Channel (2017-2028)
9.3 Latin America Prescription Cannabidiol (CBD) Oil Market Size by Country
9.3.1 Latin America Prescription Cannabidiol (CBD) Oil Sales by Country (2017-2028)
9.3.2 Latin America Prescription Cannabidiol (CBD) Oil Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Prescription Cannabidiol (CBD) Oil Market Size by Type
10.1.1 Middle East and Africa Prescription Cannabidiol (CBD) Oil Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prescription Cannabidiol (CBD) Oil Revenue by Type (2017-2028)
10.2 Middle East and Africa Prescription Cannabidiol (CBD) Oil Market Size by Sales Channel
10.2.1 Middle East and Africa Prescription Cannabidiol (CBD) Oil Sales by Sales Channel (2017-2028)
10.2.2 Middle East and Africa Prescription Cannabidiol (CBD) Oil Revenue by Sales Channel (2017-2028)
10.3 Middle East and Africa Prescription Cannabidiol (CBD) Oil Market Size by Country
10.3.1 Middle East and Africa Prescription Cannabidiol (CBD) Oil Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prescription Cannabidiol (CBD) Oil Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Jazz Pharmaceuticals plc
11.1.1 Jazz Pharmaceuticals plc Corporation Information
11.1.2 Jazz Pharmaceuticals plc Overview
11.1.3 Jazz Pharmaceuticals plc Prescription Cannabidiol (CBD) Oil Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Jazz Pharmaceuticals plc Prescription Cannabidiol (CBD) Oil Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Jazz Pharmaceuticals plc Recent Developments
11.2 Tilray Ireland
11.2.1 Tilray Ireland Corporation Information
11.2.2 Tilray Ireland Overview
11.2.3 Tilray Ireland Prescription Cannabidiol (CBD) Oil Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Tilray Ireland Prescription Cannabidiol (CBD) Oil Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Tilray Ireland Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prescription Cannabidiol (CBD) Oil Industry Chain Analysis
12.2 Prescription Cannabidiol (CBD) Oil Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Cannabidiol (CBD) Oil Production Mode & Process
12.4 Prescription Cannabidiol (CBD) Oil Sales and Marketing
12.4.1 Prescription Cannabidiol (CBD) Oil Sales Channels
12.4.2 Prescription Cannabidiol (CBD) Oil Distributors
12.5 Prescription Cannabidiol (CBD) Oil Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prescription Cannabidiol (CBD) Oil Industry Trends
13.2 Prescription Cannabidiol (CBD) Oil Market Drivers
13.3 Prescription Cannabidiol (CBD) Oil Market Challenges
13.4 Prescription Cannabidiol (CBD) Oil Market Restraints
14 Key Findings in The Global Prescription Cannabidiol (CBD) Oil Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer